Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness

American Journal of Psychiatry

Volumn 156, Issue 12, 1999, Pages 1902-1908

  Moore, Gregory J ^a   Bebchuk, Joseph M ^b   Parrish, Julieclaire K ^b   Faulk, Michael W ^b   Arfken, Cynthia L ^b   Strahl Bevacqua, Joan ^b   Manji, Husseini K ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL; LITHIUM;

ADULT; ARTICLE; BRAIN LEVEL; BRAIN SCINTISCANNING; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; FRONTAL LOBE; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; DEPRESSION, CHEMICAL; FEMALE; FRONTAL LOBE; HUMANS; INOSITOL; LITHIUM; LONGITUDINAL STUDIES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OCCIPITAL LOBE; PARIETAL LOBE; TEMPORAL LOBE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032744013     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Goodwin FK, Jamison KR: Manic-Depressive Illness. New York, Oxford University Press, 1990
2. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER: The economic burden of depression in 1990. J Clin Psychiatry 1993; 54:405-418
3. Wyatt RJ, Henter I: An economic evaluation of manic-depressive illness. Soc Psychiatry Psychiatr Epidemiol 1995; 30:213-219
4. Baldessarini RJ, Tondo L: Effects of lithium treatment and its discontinuation in bipolar disorder: overview of recent research findings from the International Consortium for Bipolar Disorders Research. Am Soc Clin Psychopharmacology Progress Notes 1997; 8(2):21-26
5. Manji HK, Lenox RH: Lithium: a molecular transducer of mood-stabilization in the treatment of bipolar disorder. Neuropsychopharmacology 1998; 19:161-166
6. Jope RS, Williams MB: Lithium and brain signal transduction systems. Biochem Pharmacol 1994; 77:429-441
7. Manji HK, Potter WZ, Lenox RH: Signal transduction pathways: molecular targets for lithium's actions. Arch Gen Psychiatry 1995; 52:531-543
8. Chou JC: Recent advances in treatment of acute mania. J Clin Psychopharmacol 1991; 11:3-21
9. Post RM, Ballenger JC, Uhde TW, Bunney WE Jr: Efficacy of carbamazepine in manic-depressive illness: implications for underlying mechanisms, in Neurobiology of Mood Disorders. Edited by Post RM, Ballenger JC. Baltimore, Williams & Wilkins, 1984, pp 777-816
10. Post RM, Frye MA, Denicoff KD, Leverich GS, Kimbrell TA, Dunn RT: Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacology 1998; 19:206-220
11. Manji HK, Chen G, Hsiao JK, Masana MI, Moore GJ, Potter WZ: Regulation of signal transduction pathways by mood-stabilizing agents, in Bipolar Medications: Mechanisms of Action. Edited by Manji HK, Bowden CL, Belmaker RH. Washington, DC, American Psychiatric Press (in press)
12. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garzatrevino ES, Risch SC, Goodnick PJ, Morris DD: Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994; 271:918-924
13. Bowden CL: New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine. Neuropsychopharmacology 1998; 19:194-200
14. Rana RS, Hokin LE: Role of phosphoinositides in transmembrane signaling. Physiol Rev 1990; 70:115-164
15. Fisher SK, Heacock AM, Agranoff BW: Inositol lipids and signal transduction in the nervous system: an update. J Neurochem 1992; 58:18-38
16. Allison JH, Stewart MA: Reduced brain inositol in lithium-treated rats. Nature New Biol 1971; 233:267-268
17. Hallcher LM, Sherman WR: The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 1980; 255:10896-10901
18. Nahorski SR, Ragan CI, Challiss RAJ: Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol Sci 1991; 12:297-303
19. + in the treatment of bipolar disorder. Trends Neurosci 1995; 18:343-349
20. Berridge MJ, Downes CP, Hanley MR: Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 1982; 206:587-595
21. Berridge MJ, Irvine RF: Inositol phosphates and cell signalling. Nature 1989; 341:197-205
22. Manji HK, Lenox RH: Lithium: a molecular transducer of mood-stabilization in the treatment of bipolar disorder. Neuropsychopharmacology 1998; 19:161-167
23. Godfrey PP: Potentiation by lithium of CMP-phosphatidate formation in carbachol-stimulated rat cerebral-cortical slices and its reversal by myo-inositol. Biochem J 1989; 258:621-624
24. Pontzer NJ, Crews FT: Desensitization of muscarinic stimulated hippocampal cell firing is related to phosphoinositide hydrolysis and inhibited by lithium. J Pharmacol Exp Ther 1990; 253:921-929
25. Kofman O, Belmaker RH: Biochemical, behavioral and clinical studies of the role of inositol in lithium treatment and depression. Biol Psychiatry 1993; 34:839-852
26. Tricklebank MD, Singh L, Jackson A, Oles RJ: Evidence that a proconvulsant action of lithium is mediated by inhibition of myo-inositol phosphatase in mouse brain. Brain Res 1991; 558:145-148
27. Ketter TA, George MS, Kimbrell TA, Willis MW, Benson BE, Post RM: Neuroanatomical models and brain-imaging studies, in Bipolar Disorder: Biological Models and Their Clinical Application. Edited by Young LT, Joffe RT. New York, Marcel Dekker, 1997, pp 179-217
28. Soares JC, Krishnan KR, Keshavan MS: Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. Depression 1996; 4:14-30
29. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME: Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386:824-827
30. Drevets WC, Ongur D, Price JL: Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry 1998; 3: 190-191, 220-226
31. Ongur D, Drevets WC, Price JL: Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95:13290-13295
32. Rajakowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC, Roth BL, Stockmeier CA: Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45:1085-1098
33. Devous MD, Rush AJ, Schlesser MA: Single-photon tomographic determination of regional cerebral blood flow in psychiatric disorders (abstract). J Nucl Med 1984; 25:P57
34. Altshuler LL, Conrad A, Hauser P, Li XM, Guze BH, Denikoff K, Tourtellotte W, Post R: Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging. Arch Gen Psychiatry 1991; 48:482-483
35. Swayze VW II, Andreasen NC, Alliger RJ, Ehrhardt JC, Yuh WT: Structural brain abnormalities in bipolar affective disorder: ventricular enlargement and focal signal hyperintensities. Arch Gen Psychiatry 1990; 47:1054-1059
36. 1H spectroscopy: glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed 1991; 4:59-63
37. Shonk T, Ross BD: Role of increased cerebral myo-inositol in the dementia of Down syndrome. Magn Reson Med 1995; 33: 858-861
38. Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-IV (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1995
39. Frahm J, Merboldt KD, Hanicke W: Localized proton spectroscopy using stimulated echoes. J Magn Reson 1987; 72:502-508
40. van den Boogaart A, Ala-Korpela M, Jokisaari J, Griffiths JR: Time and frequency domain analysis of NMR data compared: an application to 1D 1H spectra of lipoproteins. Magn Reson Med 1994; 31:347-358
41. 1H spectroscopic imaging data sets. NMR Biomed 1992; 5:171-178
42. 1: a scheme for analysis of in vivo metabolites. J Magn Reson 1983; 55:357-371
43. Soher BJ, Hurd RE, Sailasuta N, Barker PB: Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn Reson Med 1996; 36:335-339
44. Christiansen P, Henriksen O, Stubgaard M, Gideon P, Larsson H: In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Magn Reson Imaging 1993; 11: 107-118
45. 1H spectroscopic imaging of human brain at 4.1 T using image segmentation. Magn Reson Med 1996; 36:21-29
46. Frahm J, Michaelis T, Merboldt KD, Bruhn H, Gyngell ML, Hanicke W: Improvements in localized 1H NMR spectroscopy of human brain: water suppression, short echo times and 1 ml resolution. J Magn Reson 1990; 90:464-473
47. Klose U: In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 1990; 14:26-30
48. Hennig J, Pfister H, Ernst T, Ott D: Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy. NMR Biomed 1992; 5:193-199
49. Barker PB, Soher BJ, Blackband SJ, Chatham JC, Mathews VP, Ryan RN: Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed 1993; 6:89-94
50. Barker P, Breiter S, Soher B, Chatham J, Forder J, Samphilipo M, Magee C, Anderson J: Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 1994; 32:157-163
51. Frahm J, Bruhn H, Gyngell ML, Merbddt KD, Hanicke W, Sauter R: Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989; 9:79-93
52. Narayana PA, Fotedar LK, Jackson EF, Bohaw ID, Butler IJ, Wolinsky JS: Regional in vivo proton magnetic resonance spectroscopy of brain. J Magn Reson 1989; 83:44-52
53. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J: Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993; 187:219-227
54. Kreis R, Ernst T, Ross B: Absolute quantitation of water and metabolites in the human brain, II: metabolite concentrations. J Magn Reson series B 1993; 102:9-19
55. Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G: Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. J Clin Psychiatry 1999; 60(suppl 2):27-39
56. Moore GJ, Bebchuk JM, Faulk MW, Parrish JK, Strahl-Bevacqua J, Hasanat K, Manji HK: Right frontal lobe choline is decreased with lithium administration in manic depressive illness. Abstracts of the Society for Neuroscience 1998; 24(2):1847
57. Agam G, Shapiro J, Levine J, Stier S, Shields C, Bersudsky Y, Belmaker RH: Short-term lithium treatment does not reduce human CSF inositol levels. Lithium 1993; 4:267-269
58. Molchan SE, Atack JR, Sunderland T: Decreased CSF inositol monophosphatase activity after lithium treatment. Psychiatry Res 1994; 53:103-105
59. Silverstone PH, Hanstock CC, Fabian J, Staab R, Allen PS: Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS. Biol Psychiatry 1996; 40:235-246
60. Goodwin FK, Murphy DL, Dunner DL, Bunney WE Jr: Lithium response in unipolar versus bipolar depression. Am J Psychiatry 1972; 129:44-47
61. Baron M, Gershon ES, Rudy V, Jonas WZ, Buchsbaum M: Lithium carbonate response in depression: prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry 1975; 32:1107-1111
62. Mendels J: Lithium in the treatment of depressive states, in Lithium Research and Therapy. Edited by Johnson FN. New York, NY, Academic Press, 1975, pp 43-62
63. Noyes R Jr, Dempsey GM, Blum A, Cavanaugh GL: Lithium treatment of depression. Compr Psychiatry 1974; 15:187-193
64. Zornberg GL, Pope HG Jr: Treatment of depression in bipolar disorder: new directions for research. J Clin Pharmacol 1993; 13:397-408
65. Keck PE, McElroy SL: Outcome in the pharmacologic treatment of bipolar disorder. J Clin Psychopharmacol 1996; 16(suppl 1):15S-23S
66. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L: Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152: 1130-1138
67. Goodwin FK, Jamison KR: Maintenance medical treatment, in Manic-Depressive Illness. New York, Oxford University Press, 1990, pp 665-724
68. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW: Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988; 145:179-184
69. Wehr TA, Goodwin FK: Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144:1403-1411
70. Benjamin J, Agam G, Levine J, Bersudsky Y, Kofman O, Belmaker RH: Inositol treatment in psychiatry. Psychopharmacol Bull 1995; 31:167-175
71. Levine J, Barak Y, Gonzalves M, Szor H, Elizur A, Kofman O, Belmaker RH: Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry 1995; 152:792-794